サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623451

造影剤の世界市場：地域別、範囲および予測

Global Contrast Media Market by Type, By Application, By End-User, By Geographic Scope and Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
造影剤の世界市場：地域別、範囲および予測
出版日: 2024年10月22日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

造影剤の世界市場規模と予測

造影剤の世界市場は、2024年に55億4,000万米ドルと評価され、2024年から2031年にかけてCAGR 2.59%で成長し、2031年には68億米ドルに達すると予測されています。造影剤としても知られる造影剤は、医療用画像処理技術において体内構造の可視性を高めるために使用される物質です。同市場は、病院、診断センター、外来手術センターなど、さまざまなヘルスケア環境に対応しており、X線/CT、MRI、超音波など、さまざまな画像モダリティのソリューションを提供しています。

造影剤市場の将来は、慢性疾患の有病率の増加、イメージング技術の技術的進歩、低侵襲手技の需要の増加、世界の医療費の増加によって形成されます。

世界の造影剤市場力学

世界の造影剤市場を形成している主な市場力学

主な市場促進要因

慢性疾患の有病率の上昇：

慢性疾患（特に心血管疾患とがん）の世界の増加により、画像診断の需要が大幅に増加しています。この動向は、医療用画像の視認性と精度を高め、最終的に患者の転帰を改善するために不可欠な造影剤への依存度を高めることにつながります。

技術の進歩：

画像診断技術における最近の技術革新は、診断業務に革命をもたらしています。安全性プロファイルの改善とイメージング能力の向上を特徴とする新規造影剤の開発は、市場開拓において重要な役割を果たしています。これらの進歩により、より正確な診断が可能になり、ヘルスケア現場におけるより良い治療計画と患者管理が促進されます。

高齢人口の増加：

拡大する高齢者人口は、特に高度な画像診断を必要とする様々な疾病に罹患しやすいです。高齢者は通常、より頻繁な医学的評価を必要とするため、信頼性の高い画像診断ソリューションの必要性が高まり、造影剤の需要を牽引しています。この動向は、高齢者に合わせたヘルスケア戦略の重要性を強調しています。

ヘルスケア支出の増加：

先進国、発展途上国を問わずヘルスケア支出の増加は、先進的な画像技術や優れた造影剤の導入に道を開いています。このような財政支出は技術の向上を支え、医療従事者が正確な診断と効果的な治療を行えるようにし、最終的に患者の治療と転帰に利益をもたらします。

主な課題

副作用とアレルギー反応：

造影剤に関連する潜在的な副作用やアレルギー反応、特に腎障害のある患者に対する懸念は、市場成長の課題となっています。より安全な薬剤の開発が進められているとはいえ、こうしたリスクは依然として広範な普及の妨げとなっており、患者のスクリーニングとモニタリングを慎重に行う必要があります。

高コスト：

造影剤には多額のコストがかかるため、特に高度な画像診断モダリティでは、リソースに制約のあるヘルスケア環境での導入が制限される可能性があります。これらの造影剤は診断精度を向上させるが、予算が限られている小規模のクリニックやヘルスケア施設にとっては、その高価格は法外なものかもしれないです。

厳しい規制要件：

造影剤製品を取り巻く厳格な承認プロセスや規制は、市場参入を遅らせ、メーカーの開発コストを増加させる可能性があります。こうした措置は製品の安全性と有効性を保証する一方で、技術革新を遅らせ、市場で競争しようとする中小企業にとっては障壁となります。

熟練放射線科医の不足：

造影剤を投与し、鮮明な画像を読影できる訓練を受けた放射線科医や技師が世界的に不足していることは、市場拡大にとって大きな課題となっています。研修プログラムを増やす努力は行われているが、専門知識の不足は様々な地域で造影剤技術の完全活用を制限し続けています。

主要動向：

臓器特異的造影剤の開発：

特定の臓器や組織の画像化に特化した造影剤の開発傾向が高まっており、よりターゲットを絞った効率的な診断が可能となっています。

マイクロバブル造影剤の使用の増加：

マイクロバブル造影剤は、電離放射線を使用せずに画質を向上させることができるため、特に循環器科や放射線科のアプリケーションにおいて、超音波画像診断への採用が増加しています。

患者に優しい製剤へのシフト：

造影剤メーカーは、患者の不快感や副作用のリスクを最小限に抑えるため、安全性プロファイルの改善、浸透圧の低減、忍容性の向上に重点を置いた造影剤の開発に取り組んでいます。

人工知能の統合：

AIや機械学習が造影ワークフローに組み込まれ、画質の向上、造影剤投与量の削減、診断精度の向上がますます進んでいます。

目次

第1章 造影剤の世界市場イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の造影剤市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 造影剤の世界市場：タイプ別

  • 概要
  • マイクロバブル造影剤
  • ヨード系造影剤
  • ガドリニウム系造影剤
  • バリウム系造影剤

第6章 造影剤の世界市場：用途別

  • 概要
  • 放射線医学
  • インターベンショナル放射線医学
  • インターベンショナル・カーディオロジー

第7章 造影剤の世界市場：モダリティ別

  • 概要
  • X線/コンピュータ断層撮影（CT）
  • 超音波
  • 磁気共鳴画像法（MRI）

第8章 造影剤の世界市場：投与経路別

  • 概要
  • 経口
  • 血管内
  • 直腸
  • その他の投与経路

第9章 造影剤の世界市場：適応症別

  • 概要
  • 心血管疾患
  • がん
  • 消化器疾患
  • その他

第10章 造影剤の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東

第11章 世界の造影剤市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第12章 企業プロファイル

  • GE Healthcare
  • Guerbet LLC
  • Bayer AG
  • Bracco Diagnostics Inc.
  • Lantheus Medical Imaging, Inc.
  • Daiichi Sankyo Co. Ltd,
  • Fuji Pharma Co., Ltd

第13章 付録

  • 関連調査
目次
Product Code: 23716

Global Contrast Media Market Size and Forecast

The Global Contrast Media Market was valued at USD 5.54 Billion in 2024 and is projected to reach USD 6.8 Billion by 2031 growing at a CAGR of 2.59% from 2024 to 2031. Contrast media, also known as contrast agents, are substances used to enhance the visibility of internal body structures in medical imaging techniques. The market serves various healthcare settings, including hospitals, diagnostic centers and ambulatory surgical centers, offering solutions for different imaging modalities such as X-ray/CT, MRI and ultrasound.

The future of the contrast media market is shaped by increasing prevalence of chronic diseases, technological advancements in imaging techniques, growing demand for minimally invasive procedures and rising healthcare expenditure globally.

Global Contrast Media Market Dynamics

The key market dynamics that are shaping the global contrast media market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The global rise in chronic diseases, notably cardiovascular disorders and cancer, is significantly increasing the demand for diagnostic imaging procedures. This trend leads to a greater reliance on contrast media, essential for enhancing the visibility and accuracy of medical imaging, ultimately improving patient outcomes.

Technological Advancements:

Recent innovations in imaging technologies are revolutionizing diagnostic practices. The development of novel contrast agents, which feature improved safety profiles and enhanced imaging capabilities, plays a crucial role in market growth. These advancements ensure more precise diagnostics, facilitating better treatment planning and patient management in healthcare settings.

Growing Geriatric Population:

The expanding elderly population is particularly vulnerable to various diseases that necessitate advanced diagnostic imaging. As older adults typically require more frequent medical assessments, the increasing need for reliable imaging solutions drives the demand for contrast media. This trend underscores the importance of tailored healthcare strategies for seniors.

Increasing Healthcare Expenditure:

Rising healthcare expenditures in both developed and developing nations are paving the way for the adoption of advanced imaging techniques and superior contrast agents. This financial commitment supports technological upgrades, ensuring healthcare providers can deliver accurate diagnoses and effective treatments, ultimately benefiting patient care and outcomes.

Key Challenges:

Side Effects and Allergic Reactions:

Concerns about potential side effects and allergic reactions related to contrast media, especially in patients with renal impairment, present challenges for market growth. While advancements are being made to develop safer agents, these risks still hinder broader adoption and necessitate careful patient screening and monitoring.

High Costs:

The significant costs associated with contrast agents, particularly for advanced imaging modalities, can limit their adoption in resource-constrained healthcare settings. Though these agents offer improved diagnostic accuracy, their high price tags may be prohibitive for smaller clinics and healthcare facilities with limited budgets.

Stringent Regulatory Requirements:

The rigorous approval processes and strict regulations surrounding contrast media products can delay market entry and increase development costs for manufacturers. While these measures ensure product safety and efficacy, they also slow down innovation and raise barriers for smaller companies trying to compete in the market.

Shortage of Skilled Radiologists:

The global shortage of trained radiologists and technicians capable of administering contrast media and interpreting enhanced images poses a significant challenge to market expansion. While efforts are being made to increase training programs, the lack of expertise continues to limit the full utilization of contrast media technologies in various regions.

Key Trends:

Development of Organ-Specific Contrast Agents:

There is a growing trend towards the development of contrast media specifically designed for imaging particular organs or tissue types, allowing for more targeted and efficient diagnostic procedures.

Increasing Use of Microbubble Contrast Agents:

The adoption of microbubble contrast agents for ultrasound imaging is rising, particularly in cardiology and radiology applications, due to their ability to enhance image quality without ionizing radiation.

Shift Towards Patient-Friendly Formulations:

Manufacturers are focusing on developing contrast media with improved safety profiles, reduced osmolality and better tolerability to minimize patient discomfort and risk of adverse reactions.

Integration of Artificial Intelligence:

AI and machine learning are increasingly being incorporated into contrast-enhanced imaging workflows to improve image quality, reduce contrast media dose and enhance diagnostic accuracy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Contrast Media Market Regional Analysis

Here is a more detailed regional analysis of the global contrast media market:

North America:

According to Verified Market Research, North America is expected to dominate the Global contrast media market.

North America is expected to hold a significant share in the Global contrast media market due to its advanced healthcare infrastructure, high adoption rate of medical imaging technologies and presence of key market players.

The United States is a major contributor to market growth, driven by the high prevalence of chronic diseases and substantial healthcare spending.

The region's focus on early disease detection and preventive healthcare is driving the demand for diagnostic imaging procedures and, consequently, contrast media.

Canada's universal healthcare system and increasing investments in healthcare infrastructure are also contributing to the expansion of the contrast media market in the region.

Europe:

According to Verified Market Research, Europe is the fastest growing region in Global contrast media market.

Europe represents a substantial market for contrast media, driven by the region's aging population and well-established healthcare systems.

Countries like Germany, France and the UK are key contributors to market growth, with their emphasis on advanced medical imaging technologies and high-quality patient care.

The region's strong focus on research and development in medical imaging is fostering innovations in contrast media formulations and applications.

There is a growing trend towards the use of macrocyclic gadolinium-based contrast agents in Europe due to their improved safety profile.

Global Contrast Media Market: Segmentation Analysis

The Global Contrast Media Market is segmented on the basis of Type, Application, End-User and Geography.

Global Contrast Media Market, by Type

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Based on Type, the Global Contrast Media Market is divided into Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media segments. The Iodinated Contrast Media segment currently dominates the market due to its widespread use in X-ray and CT imaging procedures, which are among the most common diagnostic imaging modalities. These agents offer excellent visualization of blood vessels and organs. The Gadolinium-based Contrast Media segment is expected to show significant growth during the forecast period, driven by the increasing adoption of MRI procedures and the development of novel, safer gadolinium-based agents.

Global Contrast Media Market, by Application

X-ray/CT

MRI

Ultrasound

Based on Application, the Global Contrast Media Market is categorized into X-ray/CT, MRI and Ultrasound segments. The X-ray/CT segment currently leads the market due to the high volume of X-ray and CT procedures performed globally and the essential role of contrast media in enhancing image quality for these modalities. However, the MRI segment is expected to show rapid growth, driven by the increasing use of MRI for detailed soft tissue imaging and the development of advanced gadolinium-based contrast agents.

Global Contrast Media Market, by End-User

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Based on End-User, the Global Contrast Media Market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgical Centers. The Hospitals segment currently dominates the market due to the high volume of diagnostic imaging procedures performed in hospital settings and the availability of advanced imaging equipment. However, the Diagnostic Centers segment is expected to show the fastest growth during the forecast period, driven by the increasing trend towards outpatient imaging services and the growing number of standalone diagnostic facilities.

Global Contrast Media Market, by Geography

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Based on Geography, the Global Contrast Media Market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high healthcare expenditure and early adoption of new imaging technologies. Europe follows closely, with a strong focus on research and development in medical imaging. Asia-Pacific is the fastest-growing region, fueled by improving healthcare access, rising prevalence of chronic diseases and increasing investments in healthcare infrastructure.

Key Players

The Global Contrast Media Market study report will provide valuable insight with an emphasis on the global market. The major players in the Contrast Media Market include

GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Guerbet Group, Lantheus Medical Imaging, Inc., Nano Therapeutics Pvt. Ltd., Nemoto Kyorindo Co., Ltd., Sanochemia Pharmazeutika AG, Taejoon Pharm Co., Ltd. and Unijules Life Sciences Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

Contrast Media Market Recent Developments

In April 2024, GE Healthcare launched a new AI-powered contrast media injection system designed to optimize contrast dose and timing for personalized imaging protocols, aiming to improve image quality while reducing the risk of contrast-induced nephropathy.

In August 2024, Bayer AG announced the successful completion of a Phase III clinical trial for a novel gadolinium-based contrast agent with improved relaxivity and safety profile, potentially offering enhanced MRI imaging capabilities for neurological applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CONTRAST MEDIA MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CONTRAST MEDIA MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CONTRAST MEDIA MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Microbubble Contrast Media
  • 5.3 Iodinated Contrast Media
  • 5.4 Gadolinium-based Contrast Media
  • 5.5 Barium-based Contrast Media

6 GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Radiology
  • 6.3 Interventional Radiology
  • 6.4 Interventional Cardiology

7 GLOBAL CONTRAST MEDIA MARKET, BY MODALITY

  • 7.1 Overview
  • 7.2 X-ray/Computed Tomography (CT)
  • 7.3 Ultrasound
  • 7.4 Magnetic Resonance Imaging (MRI)

8 GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION

  • 8.1 Overview
  • 8.2 Oral
  • 8.3 Intravascular
  • 8.4 Rectal
  • 8.5 Other Routes

9 GLOBAL CONTRAST MEDIA MARKET, BY INDICATION

  • 9.1 Overview
  • 9.2 Cardiovascular Disorders
  • 9.3 Cancer
  • 9.4 Gastrointestinal Disorders
  • 9.5 Others

10 GLOBAL CONTRAST MEDIA MARKET, BY GEOGRAPHY

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 U.K.
    • 10.3.3 France
    • 10.3.4 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Rest of Asia Pacific
  • 10.5 Rest of the World
    • 10.5.1 Latin America
    • 10.5.2 Middle East

11 GLOBAL CONTRAST MEDIA MARKET COMPETITIVE LANDSCAPE

  • 11.1 Overview
  • 11.2 Company Market Ranking
  • 11.3 Key Development Strategies

12 COMPANY PROFILES

  • 12.1 GE Healthcare
    • 12.1.1 Overview
    • 12.1.2 Financial Performance
    • 12.1.3 Product Outlook
    • 12.1.4 Key Developments
  • 12.2 Guerbet LLC
    • 12.2.1 Overview
    • 12.2.2 Financial Performance
    • 12.2.3 Product Outlook
    • 12.2.4 Key Developments
  • 12.3 Bayer AG
    • 12.3.1 Overview
    • 12.3.2 Financial Performance
    • 12.3.3 Product Outlook
    • 12.3.4 Key Developments
  • 12.4 Bracco Diagnostics Inc.
    • 12.4.1 Overview
    • 12.4.2 Financial Performance
    • 12.4.3 Product Outlook
    • 12.4.4 Key Developments
  • 12.5 Lantheus Medical Imaging, Inc.
    • 12.5.1 Overview
    • 12.5.2 Financial Performance
    • 12.5.3 Product Outlook
    • 12.5.4 Key Developments
  • 12.6 Daiichi Sankyo Co. Ltd,
    • 12.6.1 Overview
    • 12.6.2 Financial Performance
    • 12.6.3 Product Outlook
    • 12.6.4 Key Developments
  • 12.7 Fuji Pharma Co., Ltd
    • 12.7.1 Overview
    • 12.7.2 Financial Performance
    • 12.7.3 Product Outlook
    • 12.7.4 Key Developments

13 Appendix

  • 13.1 Related Research